Across TCGA pan-cancer cohorts, LINC00839 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC00839 data layer compared with 18 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher LINC00839 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00839 expression acts as an unfavorable survival marker.

ESCA and UCEC are the cancer types where LINC00839 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	III,IV	0.136	0.573	.023	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC00839 tumor-vs-normal RNA expression · all LINC00839 data types